ORGO vs OPXS: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

ORGO has stronger fundamentals based on our AI analysis.

ORGO
Organogenesis Holdings Inc.
HOLD
58%
Confidence
VS
OPXS
Optex Systems Holdings Inc
SELL
70%
Confidence

ORGO vs OPXS Fundamental Comparison

Metric ORGO OPXS
Revenue $564.2M $9.1M
Net Income $37.0M $242,000.0
Net Margin 6.6% 2.6%
ROE 12.3% 1.0%
ROA 6.2% 0.8%
Current Ratio 3.62x 5.86x
Debt/Equity 0.21x 0.00x
EPS $0.15 $0.03

Green = Better metric | Red = Weaker metric

View Full ORGO Analysis →
View Full OPXS Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

ORGO vs AAPL OPXS vs MSFT ORGO vs GOOGL OPXS vs AMZN

ORGO vs OPXS: Frequently Asked Questions

Is ORGO or OPXS a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), ORGO has stronger fundamentals. ORGO is rated HOLD (58% confidence) while OPXS is rated SELL (70% confidence). This is not investment advice.

How does ORGO compare to OPXS fundamentally?

Organogenesis Holdings Inc. has ROE of 12.3% vs Optex Systems Holdings Inc's 1.0%. Net margins are 6.6% vs 2.6% respectively.

Which stock pays higher dividends, ORGO or OPXS?

ORGO has a dividend yield of N/A or no dividend while OPXS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in ORGO or OPXS for long term?

For long-term investing, consider that ORGO has HOLD rating with 58% confidence, while OPXS has SELL rating with 70% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about ORGO vs OPXS?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ORGO vs OPXS, the AI consensus favors ORGO based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.